Analyst Ratings for Protagonist Therapeutics (PTGX)
PTGX Rating Summary
PTGX Price Target Summary
- Highest: $225.00 (Wolfe Research)
- Lowest: $95.00 (JPMorgan)
- Average: $167.93
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$167.93 (+21.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$167.93 (+21.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | UBS | Alice Nettleton | New Coverage | Buy (N/A) |
184.00 (N/A) |
139.91 (138.43) |
-1.06% | Details |
| 8/10/2026 | Goldman Sachs | Richard Law | Upgrade | Buy (Neutral) |
186.00 (110.00) |
146.18 (138.43) |
-5.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
